Tracksun Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
About Tracksun Pharmaceutical
Tracksun Pharmaceutical Limited (TPL) is a Public Limited Indian Non-Government Company incorporated in India on 06 February 2017 (Seven years and 11 months 27 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ashish Kumar, Arvind Kumar, Sanjay Kumar, and Two other members serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999DL2017PLC311554
-
Company No.
311554
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
06 Feb 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Tracksun Pharmaceutical?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Kumar
|
Director | 06-Feb-2017 | Current |
|
Arvind Kumar
|
Director | 13-Feb-2017 | Current |
|
Sanjay Kumar
|
Director | 06-Feb-2017 | Current |
|
Jyoti Verma
|
Director | 13-Feb-2017 | Current |
|
Swati Bagla
|
Director | 15-Feb-2018 | Current |
Financial Performance of Tracksun Pharmaceutical.
Tracksun Pharmaceutical Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tracksun Pharmaceutical?
In 2017, Tracksun Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Tracksun Batteries Private LimitedAshish Kumar, Sanjay Kumar and 1 more are mutual person
-
Tracksun Solar Private LimitedAshish Kumar and Arvind Kumar are mutual person
-
Gharonda Projects Private LimitedAshish Kumar and Arvind Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tracksun Pharmaceutical?
Unlock and access historical data on people associated with Tracksun Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tracksun Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tracksun Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
